{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:22:42Z","timestamp":1779366162359,"version":"3.53.0"},"reference-count":17,"publisher":"Japanese Society of Veterinary Science","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1292\/jvms.19-0425","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T22:03:21Z","timestamp":1567634601000},"page":"1509-1514","source":"Crossref","is-referenced-by-count":7,"title":["Eukaryotic elongation factor 2 kinase inhibitor, A484954 potentiates          \u03b2-adrenergic receptor agonist-induced acute decrease in diastolic blood pressure in          rats"],"prefix":"10.1292","volume":"81","author":[{"given":"Tomoko","family":"KODAMA","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, School of              Veterinary Medicine, Kitasato University, Higashi 23 bancho 35-1, Towada, Aomori              034-8628, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneyoshi","family":"OKADA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, School of              Veterinary Medicine, Kitasato University, Higashi 23 bancho 35-1, Towada, Aomori              034-8628, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"YAMAWAKI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, School of              Veterinary Medicine, Kitasato University, Higashi 23 bancho 35-1, Towada, Aomori              034-8628, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Chen, J.                H., Riazy,                M., Smith,                E. M.,                Proud, C.              G., Steinbrecher,                U. P. and                Duronio,            V.          2009. Oxidized LDL-mediated macrophage survival involves            elongation factor-2 kinase. <i>Arterioscler. Thromb. Vasc.              Biol.<\/i>          29: 92\u201398.","DOI":"10.1161\/ATVBAHA.108.174599"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chen,              Z.,                Gopalakrishnan, S.              M., Bui, M.                H., Soni,                N. B.,                Warrior,            U., Johnson,                E. F.,                Donnelly, J.              B. and Glaser,                K. B.          2011. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125)            induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on            the anticancer mechanism of an eEF2 kinase inhibitor. <i>J.              Biol. Chem.<\/i>          286: 43951\u201343958.","DOI":"10.1074\/jbc.M111.301291"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kameshima,                S., Kazama,                K., Okada,                M. and                Yamawaki,              H.          2015. Eukaryotic elongation factor 2 kinase mediates            monocrotaline-induced pulmonary arterial hypertension via reactive oxygen            species-dependent vascular remodeling. <i>Am. J. Physiol.              Heart Circ. Physiol.<\/i>          308: H1298\u2013H1305.","DOI":"10.1152\/ajpheart.00864.2014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kameshima,                S., Okada,                M., Ikeda,                S.,                Watanabe,              Y. and                Yamawaki,              H.          2016. Coordination of changes in expression and            phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in            hypertrophied cardiomyocytes. <i>Biochem. Biophys.              Rep.<\/i>          7: 218\u2013224.","DOI":"10.1016\/j.bbrep.2016.06.018"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kameshima,                S., Okada,                M. and                Yamawaki,              H.          2019. Eukaryotic elongation factor 2 (eEF2) kinase\/eEF2 plays            protective roles against glucose deprivation-induced cell death in H9c2            cardiomyoblasts. <i>Apoptosis<\/i>          24: 359\u2013368.","DOI":"10.1007\/s10495-019-01525-z"},{"key":"6","unstructured":"6. Kodama,              T., Okada,                M. and                Yamawaki,              H.          2018. Mechanisms underlying the relaxation by A484954, a            eukaryotic elongation factor 2 kinase inhibitor, in rat isolated mesenteric            artery. <i>J. Pharmacol. Sci.<\/i>          137: 86\u201392."},{"key":"7","unstructured":"7. Kodama,              T., Okada,                M. and                Yamawaki,              H.          2019. Eukaryotic elongation factor 2 kinase inhibitor, A484954            inhibits noradrenaline-induced acute increase of blood pressure in rats.              <i>J. Vet. Med. Sci.<\/i>          81: 35\u201341."},{"key":"8","unstructured":"8. Nairn, A.                C. and Palfrey,                H. C.          1987. Identification of the major Mr 100,000 substrate for            calmodulin-dependent protein kinase III in mammalian cells as elongation            factor-2. <i>J. Biol. Chem.<\/i>          262: 17299\u201317303."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Okada,              M., Noma,                C.,                Yamawaki,              H. and Hara,                Y.          2013. Negative inotropic effect of carbachol and interaction            between acetylcholine receptor-operated potassium channel (K.ACh channel) and GTP            binding protein in mouse isolated atrium\u2014a novel methodological trial.              <i>J. Vet. Med. Sci.<\/i>          75: 377\u2013380.","DOI":"10.1292\/jvms.12-0369"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Price, N.                T., Redpath,                N. T.,                Severinov, K.              V., Campbell,                D. G.,                Russell, J.              M. and Proud,                C. G.          1991. Identification of the phosphorylation sites in            elongation factor-2 from rabbit reticulocytes. <i>FEBS              Lett.<\/i>          282: 253\u2013258.","DOI":"10.1016\/0014-5793(91)80489-P"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ryazanov, A.                G., Ward,                M. D.,                Mendola, C.              E., Pavur, K.                S., Dorovkov,                M. V.,                Wiedmann,              M.,                Erdjument-Bromage,              H., Tempst,                P., Parmer,                T. G.,                Prostko, C.              R., Germino,                F. J. and                Hait, W.            N.          1997. Identification of a new class of protein kinases            represented by eukaryotic elongation factor-2 kinase.          <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>          94: 4884\u20134889.","DOI":"10.1073\/pnas.94.10.4884"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Usui,              T., Nijima,                R.,                Sakatsume,              T., Otani,                K.,                Kameshima,              S., Okada,                M. and                Yamawaki,              H.          2015. Eukaryotic elongation factor 2 kinase controls            proliferation and migration of vascular smooth muscle cells.              <i>Acta Physiol. (Oxf.)<\/i>          213: 472\u2013480.","DOI":"10.1111\/apha.12354"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Usui,              T., Okada,                M., Hara,                Y. and                Yamawaki,              H.          2013. Eukaryotic elongation factor 2 kinase regulates the            development of hypertension through oxidative stress-dependent vascular            inflammation. <i>Am. J. Physiol. Heart Circ.              Physiol.<\/i>          305: H756\u2013H768.","DOI":"10.1152\/ajpheart.00373.2013"},{"key":"14","unstructured":"14. Usui,              T., Okada,                M., Hara,                Y. and                Yamawaki,              H.          2011. Exploring calmodulin-related proteins, which mediate            development of hypertension, in vascular tissues of spontaneous hypertensive            rats. <i>Biochem. Biophys. Res. Commun.<\/i>          405: 47\u201351."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yasuda,              J., Takada,                L.,                Kajiwara,              Y., Okada,                M. and                Yamawaki,              H.          2015. Endostatin inhibits bradykinin-induced cardiac            contraction. <i>J. Vet. Med. Sci.<\/i>          77: 1391\u20131395.","DOI":"10.1292\/jvms.15-0200"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhang,              P., Riazy,                M., Gold,                M., Tsai,                S. H.,                McNagny,            K., Proud,                C. and                Duronio,            V.          2014. Impairing eukaryotic elongation factor 2 kinase activity            decreases atherosclerotic plaque formation. <i>Can. J.              Cardiol.<\/i>          30: 1684\u20131688.","DOI":"10.1016\/j.cjca.2014.09.019"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhou,              Y., Li,                Y., Xu,                S., Lu,                J., Zhu,                Z., Chen,                S., Tan,                Y., He,                P., Xu,                J., Proud,                C. G., Xie,                J. and              Shen,            K.          2019. Eukaryotic elongation factor 2 kinase promotes            angiogenesis in hepatocellular carcinoma via PI3K\/Akt and STAT3.              <i>Int. J. Cancer<\/i> (In            Press).","DOI":"10.1002\/ijc.32560"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/81\/10\/81_19-0425\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T03:44:29Z","timestamp":1572061469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/81\/10\/81_19-0425\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.19-0425","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}